Immunitybio Stock Price on November 22, 2024
| IBRX Stock | USD 5.04 0.06 1.18% |
Below is the normalized historical share price chart for Immunitybio extending back to July 28, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Immunitybio stands at 5.04, as last reported on the 26th of November, with the highest price reaching 5.43 and the lowest price hitting 5.01 during the day.
If you're considering investing in Immunitybio Stock, it is important to understand the factors that can impact its price. Immunitybio appears to be very risky, given 3 months investment horizon. Immunitybio holds Efficiency (Sharpe) Ratio of 0.0818, which attests that the entity had a 0.0818% return per unit of risk over the last 3 months. By evaluating Immunitybio's technical indicators, you can evaluate if the expected return of 0.54% is justified by implied risk. Please utilize Immunitybio's Downside Deviation of 4.78, market risk adjusted performance of 0.3656, and Risk Adjusted Performance of 0.0621 to validate if our risk estimates are consistent with your expectations.
At this time, Immunitybio's Common Stock Total Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 2.5 B in 2024, despite the fact that Total Stockholder Equity is likely to grow to (557.6 M). . At this time, Immunitybio's Price To Sales Ratio is fairly stable compared to the past year. Price Sales Ratio is likely to rise to 6,720 in 2024, whereas Price Earnings Ratio is likely to drop (4.60) in 2024. Immunitybio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of July 2015 | 200 Day MA 5.2774 | 50 Day MA 4.2708 | Beta (0.43) |
Immunitybio |
Sharpe Ratio = 0.0818
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IBRX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.58 actual daily | 58 58% of assets are less volatile |
Expected Return
| 0.54 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Immunitybio is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunitybio by adding it to a well-diversified portfolio.
Enterprise Value Ebitda (8.99) | Price Sales 479 | Shares Float 165.5 M | Wall Street Target Price 14.25 | Earnings Share (0.90) |
Related Headline
BioLineRx Headline on 22nd of November 2024
BioLineRx Q3 2024 Earnings Preview by seekingalpha.com
BioLineRx is set to report Q3 earnings on Nov 25. Consensus estimates are -0.11 EPS and 5.29M revenue.
Immunitybio Valuation on November 22, 2024
It is possible to determine the worth of Immunitybio on a given historical date. On November 22, 2024 Immunitybio was worth 5.04 at the beginning of the trading date compared to the closed value of 5.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Immunitybio stock. Still, in general, we apply an absolute valuation method to find Immunitybio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immunitybio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Immunitybio's related companies.
| Open | High | Low | Close | Volume | |
| 4.91 | 5.15 | 4.84 | 5.04 | 3,366,856 | |
11/22/2024 | 5.04 | 5.16 | 4.88 | 5.10 | 3,419,676 |
| 5.24 | 5.43 | 5.01 | 5.04 | 3,149,724 |
| Backtest Immunitybio | | | Immunitybio History | | | Immunitybio Valuation | Previous | Next |
Immunitybio Trading Date Momentum on November 22, 2024
| On November 25 2024 Immunitybio was traded for 5.04 at the closing time. The top price for the day was 5.43 and the lowest listed price was 5.01 . The trading volume for the day was 3.1 M. The trading history from November 25, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.18% . The trading delta at closing time against the current closing price is 2.75% . |
Immunitybio Fundamentals Correlations and Trends
By evaluating Immunitybio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Immunitybio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Immunitybio financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Immunitybio Stock history
Immunitybio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunitybio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunitybio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunitybio stock prices may prove useful in developing a viable investing in Immunitybio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 508.6 M | 399.6 M | |
| Net Loss | -374.9 M | -356.2 M |
Immunitybio Stock Technical Analysis
Immunitybio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Immunitybio Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Immunitybio cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Immunitybio November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Immunitybio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunitybio shares will generate the highest return on investment. By undertsting and applying Immunitybio stock market strength indicators, traders can identify Immunitybio entry and exit signals to maximize returns
Immunitybio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immunitybio's price direction in advance. Along with the technical and fundamental analysis of Immunitybio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunitybio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0621 | |||
| Jensen Alpha | 0.2956 | |||
| Total Risk Alpha | (0.57) | |||
| Sortino Ratio | 0.0679 | |||
| Treynor Ratio | 0.3556 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Immunitybio Stock Analysis
When running Immunitybio's price analysis, check to measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.